Amarantus Bioscience Holdings Inc (AMBS)

[tsuguy]

I agree, and think that is good valuation going into uplist. One would have to think we would be entering uplist at least valued in the .08 SP range with previous funding arrangement at that level. I would also expect those entities to run it up into uplist.

I don't recall exactly, but didn't one of those funding arrangements have provision to free trade if an uplist occurs? I don't have time to verify at the moment, but may be worth a quick overview.